edetic acid has been researched along with epirubicin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Grankvist, K; Henriksson, R | 1 |
| Brambs, HJ; Görich, J; Kreienberg, R; Rieber, A; Rosenthal, H; Tomczak, R; Zeitler, H | 1 |
| Fujii, M; Hirota, S; Maruta, T; Matsumoto, S; Nakanishi, K; Ohno, Y; Saigo, K; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Barnert, S; Gubernator, J; Hrynyk, R; Kempińska, K; Korycińska, M; Kozubek, A; Lipka, D; Milczarek, M; Süss, R; Wietrzyk, J | 1 |
1 review(s) available for edetic acid and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for edetic acid and epirubicin
| Article | Year |
|---|---|
Protective effect of iron chelators on epirubicin-induced fibroblast toxicity.
Topics: Animals; Cell Line; Cell Survival; Deferoxamine; Drug Evaluation, Preclinical; Drug Interactions; Edetic Acid; Epirubicin; Fibroblasts; Iron Chelating Agents; Pentetic Acid | 1988 |
MRI of breast cancer: influence of chemotherapy on sensitivity.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Contrast Media; Cyclophosphamide; Edetic Acid; Epirubicin; False Negative Reactions; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 1997 |
Anticoagulant-induced pseudothrombocytopenia occurring after transcatheter arterial embolization for hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Anticoagulants; Blood Platelets; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Edetic Acid; Embolization, Therapeutic; Epirubicin; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasm Invasiveness; Platelet Count; Portal Vein; Thrombocytopenia | 2006 |
Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of epirubicin prepared using the EDTA ion gradient method.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Edetic Acid; Epirubicin; Humans; Kinetics; Liposomes; Male; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2014 |